Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-01

FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Chantix (varenicline tartrate) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)

Snippet

SUPPL AP for CHANTIX (VARENICLINE TARTRATE)